More recently, α-KG has been identified as a radiosensitizer for lung cancer treatment in combination with CTPI-2, an inhibitor of mitochondrial citrate carrier (SLC25A1; CIC), whereas α-KG alone had no pharmacological effects (95). Here, SLC25A1 is linked to lung cancer.